Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

PROTAGONIST THERAPEUTICS, INC.

(PTGX)
  Report
Delayed Nasdaq  -  04:00:00 2023-02-07 pm EST
15.83 USD   +5.82%
01/11Transcript : Protagonist Therapeutics, Inc. Presents at 41st Annual J.P. Morgan Healthcare Conference, Jan-11-2023 07:30 AM
CI
01/06Protagonist Therapeutics, Inc : Change in Directors or Principal Officers (form 8-K)
AQ
01/06Protagonist Therapeutics, Inc. Announces David Liu, Chief R&D Strategy Officer, Transitioned to Part-Time R&D Strategy Advisor
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Event chart PROTAGONIST THERAPEUTICS, INC.
Upcoming events on PROTAGONIST THERAPEUTICS, INC.
03/08/23 FY 2022 Earnings Release (Projected)
05/10/23 Q1 2023 Earnings Release (Projected)
08/08/23 Interim 2023 Earnings Release (Projected)
11/07/23 Q3 2023 Earnings Release (Projected)
Past events on PROTAGONIST THERAPEUTICS, INC.
01/09/23 | 11:00am JP Morgan Healthcare Conference
12/12/22 American society of hematology meeting - session name: 102
12/12/22 American society of hematology meeting - session name: 634
12/10/22 | 06:30pm American society of hematology meeting - session name: 634
12/06/22 | 11:40am JMP Securities Hematology Oncology Summit
11/08/22 | 04:05pm Q3 2022 Earnings Release
10/10/22 | 12:30pm United European Gastroenterology Week - Abstract #ASUEG202203120
08/04/22 | 04:05pm Interim 2022 Earnings Release
06/08/22 | 09:30am Jefferies Healthcare Conference
06/07/22 | 11:45am American society of clinical oncology meeting - abstract number: #7003
Past dividends on PROTAGONIST THERAPEUTICS, INC.

- No events available -

Annual results
Fiscal Period : December201720182019202020212022
Sales
M $
Released
Forecast
Spread
20,1
17,7
14%
30,9
33,6
-8,0%
0,23
1,74
-87%
28,6
25,7
11%
27,4
23,2
18%
 
31,5
 
Operating income
(EBITDA)
M $
Released
Forecast
Spread


 


 


 
-63,7
-68,7
7,2%
-125
-135
7,4%
 
-128
 
Operating profit
(EBIT)
M $
Released
Forecast
Spread
-37,9
-42,0
9,8%
-42,3
-38,2
-11%
-80,5
-81,8
1,5%
-64,5
-65,4
1,3%
-126
-128
1,5%
 
-128
 
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
-37,0
-41,0
9,9%
-39,7
-37,8
-5,1%
-77,9
-79,3
1,8%
-64,8
-64,1
-1,1%
-126
-128
2,1%
 
-127
 
Net income
M $
Released
Forecast
Spread
-37,0
-41,0
9,9%
-38,9
-36,0
-8,0%
-77,2
-77,9
0,89%
-66,2
-66,2
0,04%
-126
-128
1,9%
 
-127
 
EPS
$
Released
Forecast
Spread
-2,09
-2,29
8,9%
-1,74
-1,67
-4,4%
-2,98
-3,00
0,60%
-1,92
-1,94
0,84%
-2,71
-2,73
0,78%
 
-2,56
 
Announcement Date03/07/201803/12/201903/10/202003/10/202102/28/2022-
Quarterly results
Fiscal Period : December2021 Q32021 Q42022 Q12022 Q22022 Q32022 Q4
Sales
M $
Released
Forecast
Spread
10,3
1,74
490%
8,62
4,44
94%
25,7
17,1
51%
0,86
0,38
124%


 
 
5,00
 
Operating income
(EBITDA)
M $
Released
Forecast
Spread
-33,7
-35,0
3,7%
-36,8
-46,0
20%
-20,9
-50,0
58%
-41,2
-52,0
21%
-32,0
-43,0
26%
 
-33,0
 
Operating profit
(EBIT)
M $
Released
Forecast
Spread
-33,9
-31,5
-7,8%
-37,0
-39,0
5,0%
-21,1
-27,8
24%
-41,4
-46,3
11%
-32,3
-43,3
25%
 
-32,2
 
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
-33,8
-33,0
-2,4%
-36,9
-39,4
6,4%
-20,9
-31,6
34%
-41,0
-48,9
16%
-31,2
-41,7
25%
 
-33,6
 
Net income
M $
Released
Forecast
Spread
-33,8
-31,8
-6,2%
-36,9
-39,3
6,1%
-20,9
-30,4
31%
-41,0
-45,9
11%
-31,2
-43,0
27%
 
-32,0
 
EPS
$
Released
Forecast
Spread
-0,70
-0,68
-2,6%
-0,77
-0,79
2,4%
-0,43
-0,63
32%
-0,84
-0,94
10%
-0,64
-0,87
26%
 
-0,64
 
Announcement Date11/03/202102/28/202205/04/202208/04/202211/08/2022-
Previous year Next Year
Upcoming sector events for PROTAGONIST THERAPEUTICS, INC.
More events
Past sector events for PROTAGONIST THERAPEUTICS, INC.
More events
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise